Works by Gan, Hualei


Results: 21
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapy

    Published in:
    BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12395-3
    By:
    • Wang, Beihe;
    • Pan, Jian;
    • Zhang, Tingwei;
    • Ni, Xudong;
    • Wei, Yu;
    • Li, Xiaomeng;
    • Fang, Bangwei;
    • Hu, Xiaoxin;
    • Gan, Hualei;
    • Wu, Junlong;
    • Wang, Hongkai;
    • Ye, Dingwei;
    • Zhu, Yao
    Publication type:
    Article
    14
    15

    SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0809-0
    By:
    • Ma, Jian;
    • Chang, Kun;
    • Peng, Jingtao;
    • Shi, Qing;
    • Gan, Hualei;
    • Gao, Kun;
    • Feng, Kai;
    • Xu, Fujiang;
    • Zhang, Hailiang;
    • Dai, Bo;
    • Zhu, Yao;
    • Shi, Guohai;
    • Shen, Yijun;
    • Zhu, Yiping;
    • Qin, Xiaojian;
    • Li, Yao;
    • Zhang, Pingzhao;
    • Ye, Dingwei;
    • Wang, Chenji
    Publication type:
    Article
    16
    17
    18
    19
    20
    21